Pharmaids Pharmaceuticals Limited reported earnings results for the fourth quarter ended March 31, 2024. For the fourth quarter, the company reported sales was INR 58.06 million. Revenue was INR 59.25 million.

Net loss was INR 55.2 million compared to INR 61.62 million a year ago. Basic loss per share from continuing operations was INR 2.82 compared to INR 4.76 a year ago. Diluted loss per share from continuing operations was INR 2.82 compared to INR 4.76 a year ago.